Effect of Cross-Linking Density on the Structures and Properties of Carbodiimide-Treated Gelatin Matrices As Limbal Stem Cell Niches
Overview
Chemistry
Molecular Biology
Affiliations
Given that human amniotic membrane is a valuable biological material not readily available for corneal epithelial tissue engineering, gelatin is considered as a potential alternative to construct a cellular microenvironment. This study investigates, for the first time, the influence of cross-linking density of carbodiimide-treated gelatin matrices on the structures and properties of artificial limbal stem cell niches. Our results showed that an increase in the carbodiimide concentration from 1.5 to 15 mM leads to an upward trend in the structural and suture strength of biopolymers. Furthermore, increasing number of cross-linking bridges capable of linking protein molecules together may reduce their crystallinity. For the samples treated with 50 mM of cross-linker (i.e., the presence of excess -substituted carbodiimide), abundant -acylurea was detected, which was detrimental to the in vitro and in vivo ocular biocompatibility of gelatin matrices. Surface roughness and stiffness of biopolymer substrates were found to be positively correlated with carbodiimide-induced cross-link formation. Significant increases of integrin β1 expression, metabolic activity, and ABCG2 expression were noted as the cross-linker concentration increased, suggesting that the bulk crystalline structure and surface roughness/stiffness of niche attributed to the number of cross-linking bridges may have profound effects on a variety of limbal epithelial cell behaviors, including adhesion, proliferation, and stemness maintenance. In summary, taking the advantages of carbodiimide cross-linking-mediated development of gelatin matrices, new niches with tunable cross-linking densities can provide a significant boost to maintain the limbal stem cells during ex vivo expansion.
Digital light processing printing of non-modified protein-only compositions.
Bunin A, Harari-Steinberg O, Kam D, Kuperman T, Friedman-Gohas M, Shalmon B Mater Today Bio. 2025; 30():101384.
PMID: 39790486 PMC: 11714671. DOI: 10.1016/j.mtbio.2024.101384.
Water-Insoluble, Thermostable, Crosslinked Gelatin Matrix for Soft Tissue Implant Development.
Varga V, Smeller L, Vardai R, Kocsis B, Zsoldos I, Cruciani S Int J Mol Sci. 2024; 25(8).
PMID: 38673921 PMC: 11050114. DOI: 10.3390/ijms25084336.
Bui H, Su Y, Yang C, Huang C, Lai J J Nanobiotechnology. 2024; 22(1):160.
PMID: 38589911 PMC: 11000383. DOI: 10.1186/s12951-024-02448-x.
Olguin Y, Selva M, Benavente D, Orellana N, Montenegro I, Madrid A Pharmaceutics. 2023; 15(12).
PMID: 38140099 PMC: 10747664. DOI: 10.3390/pharmaceutics15122760.
Moderate-Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein-2.
Dorogin J, Hochstatter H, Shepherd S, Svendsen J, Benz M, Powers A Adv Healthc Mater. 2023; 12(26):e2300793.
PMID: 37379021 PMC: 10592408. DOI: 10.1002/adhm.202300793.